Evidence map›Paper›PMID 16601207›Full record

ArticleRNA (New York, N.Y.)2006

CUG-BP binds to RNA substrates and recruits PARN deadenylase.

Karen C M Moraes, Carol J Wilusz, Jeffrey Wilusz

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 180 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Ythdf mCell reports · 2020
    Article
  16. Article
  17. Article
  18. Advances in the role of mCell & bioscience · 2020
    Review
  19. Review
  20. Review

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Karen C M MoraesDepartment of Microbiology, Immunology & Pathology, College of Veterinary Medicine & Biomedical Sciences, Colorado State University, Fort Collins, 80523, USA.
Carol J Wilusz
Jeffrey Wilusz
Colorado State University · US

Funding

Regulation of mRNA Decapping in Human CellsR01GM063832 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI WILUSZ, JEFFREY · 2001 to 2004
$1.0M
NIGMS NIH HHS GM063832NIGMS NIH HHS R01 GM063832
6 · The paper itself

Abstract

CUG-BP is the human homolog of the Xenopus EDEN-BP, which was shown previously to bind to mRNAs, such as c-mos, that exhibit rapid deadenylation following fertilization of the oocyte. While several studies have focused on roles of CUG-BP as a splicing or translation regulator in mammalian cells, its role in mRNA decay has not been examined in detail. Here, we have used an in vitro deadenylation assay to dissect the function of CUG-BP in the decay of two ARE-containing mRNAs: c-fos and TNFalpha. CUG-BP binds specifically to both of these RNAs and stimulates poly(A) shortening by PARN. Moreover, CUG-BP interacts with PARN in extracts by coimmunoprecipitation, and this interaction can be recapitulated using recombinant proteins. CUG-BP, therefore, is the first RNA-binding protein shown to directly recruit a deadenylase to an RNA substrate.

Indexed as

Base SequenceCELF1 ProteinCells, CulturedCytoplasmExoribonucleasesHeLa CellsHumansImmunoprecipitationMolecular Sequence DataProtein BindingProto-Oncogene Proteins c-fosRecombinant ProteinsRNA-Binding ProteinsRNA, MessengerSubstrate SpecificityTumor Necrosis Factor-alphaCELF1 ProteinCELF1 protein, humanExoribonucleasesProto-Oncogene Proteins c-fosRecombinant ProteinsRNA-Binding ProteinsRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID16601207
PMCPMC1464848
OpenAlexW1973555390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.